comparative effectiveness

Research in Review

Chemotherapy May Be Overused Among Patients With Colon Cancer

02/09/2017

JCP Editors

Chemotherapy may be overused among young and middle-aged patients with colon cancer, according to a study published in JAMA Surgery (published online January 25, 2017; doi: 10.1001/jamasurg.2016.5050). ----- Related...

...

02/09/2017

Journal of Clinical Pathways

Research in Review

Antiandrogen Therapy Improves Survival After Prostate Cancer Recurrence

02/07/2017

JCP Editors

Radiation therapy plus bicalutamide improves long-term survival for men with recurring prostate cancer after initial surgery, according to a study published in the New England Journal of Medicine...

...

02/07/2017

Journal of Clinical Pathways

Research in Review

Comparative Effectiveness Study Identifies Best Therapy Regimens for Patients With NSCLC

02/02/2017

JCP Editors

A new study comparing first-line therapies for patients with advanced non-small cell lung cancer (NSCLC) suggests a survival advantage of one treatment regimen in younger patients, published in the Journal of Managed...

A new...

02/02/2017

Journal of Clinical Pathways

Research in Review

Less-Frequent Dosing Noninferior to Standard Dosing of Bone-Modifying Agent for Breast Cancer

01/30/2017

JCP Editors

A less-frequent dosing schedule of a bone-modifying agent (BMA) for treatment of skeletal-related events related to metastatic breast cancer is noninferior to standard dosing, according to research published in JAMA...

A...

01/30/2017

Journal of Clinical Pathways

Research in Review

Women Treated for Precursor of Breast Cancer Live Longer Than Other Women

01/27/2017

JCP Editors

Women aged 50 years or older who have been treated for ductal carcinoma in situ (DCIS) are likely to live longer than women in the general population, according to a presentation at the European Cancer Congress...

Women...

01/27/2017

Journal of Clinical Pathways

Research in Review

Best Treatment Course for Brain Metastases in EGFR Lung Cancer Identified

01/27/2017

JCP Editors

The best sequence of treatment strategies has been identified for patients with epidermal growth factor receptor (EGFR)-mutant lung cancer and brain metastases, according to an article published in the Journal of...

The...

01/27/2017

Journal of Clinical Pathways

Research in Review

Comparative Effectiveness Report Favors Aromatase Inhibitors Over Tamoxifen for Early-Stage Breast Cancer

01/04/2017

JCP Editors

Treatment with aromatase inhibitors improves outcomes versus treatment with tamoxifen for patients with early-stage breast cancer, according to a report published by the German Institute for Quality and Efficiency in...

...

01/04/2017

Journal of Clinical Pathways

Research in Review

Decreased PSA Screening Leads to Higher Rates of Metastatic Prostate Cancer in Older Men

01/03/2017

JCP Editors

Increase in metastatic prostate cancer in older men has a definitive correlation with changes in prostate cancer screening guidelines recommending against prostate-specific antigen (PSA) testing, according to...

...

01/03/2017

Journal of Clinical Pathways

Research in Review

Reduced Radiation Improves Cure Rates for Oropharyngeal Cancers

12/30/2016

JCP Editors

Patients with human papillomavirus (HPV)-associated oropharyngeal squamous cell carcinomas may have higher chances of being cured if treated with reduced doses of radiation, according to a new study published in the...

...

12/30/2016

Journal of Clinical Pathways

Research in Review

Varying Toxicities Between EGFR-TKIs for Treatment of NSCLC

12/29/2016

JCP Editors

Varying degrees of toxicity risks between different epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) can help inform treatment decisions for individual patients with non-small cell lung...

...

12/29/2016

Journal of Clinical Pathways